EU advises against AstraZeneca vaccine for people with blood vessel syndrome

11 June 2021, 14:04

AstraZeneca vaccine
Coronavirus – Wed May 12, 2021. Picture: PA

The European Medicines Agency said it reviewed cases of six people who had capillary leak syndrome after they had received the vaccine.

The EU drug regulator is recommending that people who have had a rare blood vessel syndrome are not immunised with AstraZeneca’s Covid-19 vaccine.

In a statement on Friday, the European Medicines Agency said it reviewed cases of six people who had capillary leak syndrome after they had received the AstraZeneca vaccine.

The vaccine has previously been linked to rare blood clots, but health officials say its benefits still outweigh the small risks.

EMA experts also concluded that the capillary leak condition should be added to the product information as a new side-effect of the vaccine.

HEALTH Coronavirus
(PA Graphics)

The agency said it is continuing its review of heart inflammation in a small number of people who developed conditions after being immunised with vaccines made by Pfizer-BioNTech and Moderna.

The EMA said it is studying cases of myocarditis, inflammation of the heart, and pericarditis, inflammation of the membrane surrounding the heart. Symptoms include shortness of breath and chest pain, although the problems are usually temporary.

“Further analysis is needed to determine whether there is a causal link with the vaccines,” the EU agency said.

The EMA said it expects to finalise its review of such cases next month.

Meanwhile, the EMA approved a new manufacturing site for the Moderna vaccine in a move that could substantially boost production for the European Union.

The regulator said it had approved a site in Monts, France, operated by Recipharm. In addition to the new approval, the EMA authorised several other sites to conduct batch control and testing.

This month, two locations in the US were approved for production of vaccines destined for the 27-nation EU bloc. Any medicines or vaccines authorised for the EU market must first have their production facilities approved by the EMA.

The agency said the newly approved sites are expected to result in an additional one to two million vials of Moderna’s vaccine every month.

By Press Association

Latest World News

See more Latest World News

South Africa Bus Crash

Girl, 8, the sole survivor as 45 die in bus crash off South Africa bridge

A spokesman has denied reports the sausage dog could be banned.

The wurst news is over: Germany denies claims of sausage dog ban

Israel Palestinians Britain Aid

UN top court orders Israel to open more land crossings into Gaza

Greece Confidence Vote

Greece’s government survives no-confidence motion called over rail disaster

Israel Palestinians UN Security Council

Russia ‘abolishes’ monitoring of sanctions on North Korea with UN veto

Firefighters at the scene of a bus crash in Limpopo

Bus plunges from bridge in South Africa and erupts into flames, killing at least 45 and leaving child, 8, as lone survivor

Music-Green Day UN

Green Day to headline UN-backed global climate concert

Sam Bankman-Fried

FTX founder Bankman-Fried sentenced to 25 years in prison for crypto fraud

France Valentino

Former Gucci designer Alessandro Michele named Valentino creative director

Russia Shooting

Russia arrests another suspect in concert hall attack that killed 143

American Easter egg

White House’s annual Easter egg roll to be attended by 40,000 people

Barbers in Paris

Proposal to ban discrimination over a person’s hair passes first legal hurdle

Mahmoud Abbas

Palestinian Authority names new government following pressure to reform

Arvind Kejriwal

Opposition leader Kejriwal locked up for further four days, court rules

Resident clears rubble from home

Russia wears down Ukrainian defences with missile and drone attacks

Pope Francis

Pope urges priests to avoid ‘clerical hypocrisy’ in Maundy Thursday speech